Refining Transgenic Mice

Volume 16 | Issue 13 | 34 | Jun. 24, 2002 Previous | Next Refining Transgenic Mice Emerging technologies allow researchers to make tissue- and developmental stage-specific knockouts | By Leslie Pray Image: Courtesy of Taconic Farms MOUSE HOUSE: Scientists at Taconic's Molecular Analysis Laboratory genotype transgenic rat and mouse lines. Mice have been freeloading on humans for millenni

Written byLeslie Pray
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Mice have been freeloading on humans for millennia. Now, in laboratories around the world, scientists are returning the favor. Model systems such as the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans are actually easier to work with than mice, but mice are more closely related to humans, making them better models of human physiology. "For modeling genetic diseases like breast cancer, you definitely need mammals," says Kay-Uwe Wagner, a molecular biologist at the Eppley Institute for Research in Cancer and Allied Diseases, Omaha, Neb.

Early in the 20th century, geneticists used inbred mouse strains for much of their work.1 Long before the true nature of a gene was understood, geneticists were using inbred mice--genetically identical animals, akin to identical twins--to map murine genes. These early mice had other uses, too: they served as xenograft hosts and helped researchers tease apart the nuances of the immune system.

In the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies